Clinical Trials
2 trialsNCT02907099 2025-02-19
Pembrolizumab and CXCR4 Antagonist BL-8040 in Treating Patients With Metastatic Pancreatic Cancer
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01010880 2011-06-10
Safety Study of a Chemokine Receptor (CXCR4) Antagonist in Multiple Myeloma Patients
Biokine Therapeutics Ltd
Phase 1/2 Completed